Mark J. Enyedy, Chief Executive Officer at IMMUNOGEN INC (IMGN), bought 25,000 shares at $1.83 ($46K) on 2016-11-08, disclosed to the SEC on 2016-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMGN | SELL | 2020-02-25 | $551K | — | Filing → |
| IMGN | SELL | 2019-02-25 | $286K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $1.5M | — | Filing → |